BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $112 at Barclays
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $67.36 -1.71%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $112.00 (from $114.00) while maintaining a Overweight rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at Canaccord
- Travel Food Services (TRAVELFO:IN) PT Raised to INR1,600 at ICICI Securities
- Stantec Inc. (STN:CN) (STN) PT Lowered to Cdn$169 at Desjardins
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
